William C Denby Net Worth & Insider Trades

William C Denby Adamis Pharmaceuticals Corp

As of May 28, 2019

What is William C Denby's Net Worth?

The current estimated net worth of Adamis Pharmaceuticals Corp's William C Denby is estimated to be about $10.43K . William C Denby owns about 108,750 units of Adamis Pharmaceuticals Corp common stock. In the last 5 years at Adamis Pharmaceuticals Corp, William C Denby has sold an estimated value of $0 worth.

What is William C Denby's Past Insider Trading?

William C Denby's largest purchase order was 6,250 units , worth over $10K on May 28, 2019. In total, William C Denby has made about 8 transactions over 5 years of their time at Adamis Pharmaceuticals Corp. William C Denby usually trades in May, with the busiest year in 2014.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

William C Denby

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Adamis Pharmaceuticals Corp's Past Insider Trades?

Adamis Pharmaceuticals Corp's most recent insider trade came on March 22, 2022 by Ronald Moss who sold 8,199 units worth $4.95K . In the last 12 years, insiders at Adamis Pharmaceuticals Corp have sold an estimated value of $2.05M and bought an estimated value of $2.69M worth of shares. Insider trading is most common in February, with the busiest year in 2019. The most active traders at the company are David Marguglio, SVP and Chief Business Officer,  Phd Dennis Carlo,  and Robert O Hopkins, Chief Financial Officer .

Adamis Pharmaceuticals Corp Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...